Mode
Text Size
Log in / Sign up
N/A Completed N=144 Randomized Single-blind Prevention

INcreasing Veteran EngagemeNT to Prevent Diabetes (INVENT)

Source: ClinicalTrials.gov NCT03403231 ↗
Enrolled (actual)
144
Serious AEs
0.0%
Results posted
Jun 2021
Primary outcomePrimary: Engagement in Recommended Behaviors to Prevent Type 2 Diabetes — 2; 5; 5; 2 Participants

Summary

This study will evaluate a VA MyHealtheVet Secure Messaging intervention that uses different intervention messaging strategies designed to increase engagement in behaviors to prevent type 2 diabetes. The investigators will enroll 144 eligible Veterans into a 12-week MyHealtheVet Secure Messaging intervention. Eligible Veterans include those who are currently using MyHealtheVet secure messaging, meet inclusion/exclusion criteria, and have received an HbA1c test within the last 6 months that meets the ADA/CDC classification for prediabetes. Study participants will be surveyed about their engagement in behaviors to prevent TDM2 and mediators of this engagement. After completing a baseline survey, participants will be randomly assigned to receive different novel presentations of information about ways to prevent T2DM through both Secure Messaging and US Mail. The investigators will test the 5 presentations that each: (1) represent an innovative approach from behavioral economics or health psychology with great promise to increase engagement in behaviors to prevent T2DM among patients with prediabetes; and (2) have not been tested in this setting.

Outcome Measures

OutcomeResultp-value
PRIMARY
Engagement in Recommended Behaviors to Prevent Type 2 Diabetes
2; 5; 5; 2; 2; 3
SECONDARY
Motivation to Prevent Type 2 Diabetes
.375; -1.222; -0.444; -0.222; 0.429; 0.000
SECONDARY
Importance of Preventing Type 2 Diabetes
-0.625; -0.889; -0.444; -0.222; 0.714; 0.000
SECONDARY
Use of Medication for T2DM Prevention
0; 1; 1; 0; 0; 0
SECONDARY
Perception for Risk for T2DM
-8.750; -1.111; 6.667; -4.444; 0.000; 1.111
SECONDARY
Knowledge of Strategies to Prevent T2DM
0; -0.222; -0.222; -0.222; 0.125; -0.444
SECONDARY
Participation in Weight-related Wellness Programs
0; 0; 0; 0; 1; 0
SECONDARY
Weight Loss Behaviors
2; 5; 5; 2; 3; 4
SECONDARY
Physical Activity
5; 4; 6; 7; 4; 5

Eligibility Criteria

Inclusion Criteria

  • HbA1c test within the past 6 months that meets the ADA/CDC requirements for prediabetes.
  • Currently registered in the VA's MyHealtheVet Secure Messaging System
  • Receiving care within the Ann Arbor VA Healthcare System

Exclusion Criteria

  • Completed more than 4 VA MOVE! classes in the last year (or other evidence of another recent weight loss program)
  • Are trying to lose weight and are very physically active
  • Are >75 years of age
  • Are pregnant or plan to be
  • Are taking Metformin
  • Have participated in the FINDIT study (this study's predecessor under the same grant funding)
  • Have been hospitalized or received rehab for stroke or myocardial infarction within past 6 months
  • Have received chemotherapy for cancer in the past 6 months
  • Self-report or have any International Classification of Diseases (ICD-9/10) codes for:
  • Diabetes
  • Dementia
  • Major functional limitations
  • Cirrhosis
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage 4 chronic obstructive pulmonary disease (COPD)
  • End stage renal disease (ESRD)
  • New York Heart Association (NYHA) class III or IV congestive heart failure (CHF)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03403231). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search